US Patent Issued to INSTITUT CURIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ECOLE NATIONALE SUPERIEURE DES MINES DE PARIS, UNIVERSITE DE VERSAILLES-SAINT-QUENTIN-EN-YVELINES on May 20 for "Device and method for predicting a relapse of a cancer for a patient" (French Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,308,126, issued on May 20, was assigned to INSTITUT CURIE (Paris), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris), ECOLE NATIONALE SUPERIEURE DES MINES DE PARIS (Paris) and UNIVERSITE DE VERSAILLES-SAINT-QUENTIN-EN-YVELINES (Versailles, France).

"Device and method for predicting a relapse of a cancer for a patient" was invented by Marvin Lerousseau (Paris), Thomas Walter (Paris), Anne Vincent-Salomon (Paris) and Francois-Clement Bidard (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method and a device for training a prediction model configured to predict a risk of relapse of a patient afflicted with cancer from a whole histol...